Peripherally induced resiniferatoxin analgesia

Pain

Volumn 104, Issue 1-2, 2003, Pages 219-228

  Neubert, John K ^a,c   Karai, Laszlo ^a   Jun, Jae H ^b   Kim, Hyung Suk ^a   Olah, Zoltan ^a   Iadarola, Michael J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b New York Presbyterian Hospital   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Analgesia; Pain; Rat; Resiniferatoxin; Vanilloid 1 receptor

Indexed keywords

PROTEIN C FOS; PROTEIN SUBUNIT; RESINIFERATOXIN; VANILLOID RECEPTOR;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ATTENUATION; CHRONIC DRUG ADMINISTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HEAT; HEAT SENSATION; HYPERALGESIA; INFLAMMATION; INJECTION; MALE; MOTOR PERFORMANCE; NERVE DEGENERATION; NERVE ENDING; NERVE FIBER C; NERVE POTENTIAL; NERVE REGENERATION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PAIN ASSESSMENT; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; SENSORY NERVE; SHORT COURSE THERAPY; SIGNAL TRANSDUCTION;

EID: 0038161227     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00009-5     Document Type: Article

References (39)

1. Adler P. The use of bupivacaine for blocking the Gasserian ganglion in major trigeminal neuralgia. Int J Oral Surg. 4:1975;251-257.
2. Appendino G., Cravotto G., Palmisano G., Annunziata R., Szallasi A. Synthesis and evaluation of phorboid 20-homovanillates: discovery of a class of ligands binding to the vanilloid (capsaicin) receptor with different degrees of cooperativity. J Med Chem. 39:1996;3123-3131.
3. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 288:2000;306-313.
4. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 389:1997;816-824.
5. Davis J.B.J., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., Harries M.H., Latcham J., Clapham C., Atkinson K., Hughes S.A., Rance K., Grau E., Harper A.J., Pugh P.L., Rogers D.C., Bingham S., Randall A., Sheardown S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 405:2000;183-187.
6. Davis J.B.J., Gray J., Smith G.D., Davies C.H., Randall A.D., Smart D., Rami H.K., Wyman P.A. Identification of a potent and selective antagonist of vanilloid receptor-1, SB-366791. Soc Neurosci Abstr. 27:2001.
7. Dickenson A., Hughes C., Rueff A., Dray A. A spinal mechanism of action is involved in the antinociception produced by the capsaicin analogue NE 19550 (olvanil). Pain. 43:1990;353-362.
8. Dray A. Mechanism of action of capsaicin-like molecules on sensory neurons. Life Sci. 51:1992;1759-1765.
9. Eun S.Y., Jung S.J., Park Y.K., Kwak J., Kim S.J., Kim J. Effects of capsaicin on Ca(2+) release from the intracellular Ca(2+) stores in the dorsal root ganglion cells of adult rats. Biochem Biophys Res Commun. 285:2001;1114-1120.
10. Farkas-Szallasi T., Bennett G.J., Blumberg P.M., Hokfelt T., Lundberg J.M., Szallasi A. Vanilloid receptor loss is independent of the messenger plasticity that follows systemic resiniferatoxin administration. Brain Res. 719:1996;213-218.
11. Goso C., Piovacari G., Szallasi A. Resiniferatoxin-induced loss of vanilloid receptors is reversible in the urinary bladder but not in the spinal cord of the rat. Neurosci Lett. 162:1993;197-200.
12. Goto F., Ishizaki K., Yoshikawa D., Obata H., Arii H., Terada M. The long lasting effects of peripheral nerve blocks for trigeminal neuralgia using high concentration of tetracaine dissolved in bupivacaine. Pain. 79:1999;101-103.
13. Guo A., Vulchanova L., Wang J., Li X., Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci. 11:1999;946-958.
14. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
15. Helliwell R.J., McLatchie L.M., Clarke M., Winter J., Bevan S., McIntyre P. Capsaicin sensitivity is associated with the expression of the vanilloid (capsaicin) receptor (VR1) mRNA in adult rat sensory ganglia. Neurosci Lett. 250:1998;177-180.
16. Iadarola M.J., Berman K.F., Zeffiro T.A., Byas-Smith M.G., Gracely R.H., Max M.B., Bennett G.J. Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET. Brain. 121:(Pt 5):1998;931-947.
17. Iadarola M.J., Douglass J., Civelli O., Naranjo J.R. Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization. Brain Res. 455:1988;205-212.
18. Kissin I., Bright C.A., Bradley E.L. Jr. Selective and long-lasting neural blockade with resiniferatoxin prevents inflammatory pain hypersensitivity. Anesth Analg. 94:2002;1253-1258. (table of contents).
19. LaMotte R.H., Lundberg L.E., Torebjork H.E. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol. 448:1992;749-764.
20. Lee Y.S., Lee J.A., Jung J., Oh U., Kaang B.K. The cAMP-dependent kinase pathway does not sensitize the cloned vanilloid receptor type 1 expressed in xenopus oocytes or Aplysia neurons. Neurosci Lett. 288:2000;57-60.
21. Liu L., Simon S.A. A rapid capsaicin-activated current in rat trigeminal ganglion neurons. Proc Natl Acad Sci USA. 91:1994;738-741.
22. Mardy S., Miura Y., Endo F., Matsuda I., Sztriha L., Frossard P., Moosa A., Ismail E.A., Macaya A., Andria G., Toscano E., Gibson W., Graham G.E., Indo Y. Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. Am J Hum Genet. 64:1999;1570-1579.
23. McCleane G. The analgesic efficacy of topical capsaicin is enhanced by glyceryl trinitrate in painful osteoarthritis: a randomized, double blind, placebo controlled study. Eur J Pain. 4:2000;355-360.
24. Noguchi K., Kowalski K., Traub R., Solodkin A., Iadarola M.J., Ruda M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Brain Res Mol Brain Res. 10:1991;227-233.
25. Nolano M., Simone D.A., Wendelschafer-Crabb G., Johnson T., Hazen E., Kennedy W.R. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain. 81:1999;135-145.
26. Olah Z., Karai L., Iadarola M.J. Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem. 276:2001;31163-31170.
27. Olah Z., Szabo T., Karai L., Hough C., Fields R.D., Caudle R.M., Blumberg P.M., Iadarola M.J. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem. 276:2001;11021-11030.
28. Ossipov M.H., Bian D., Malan T.P. Jr., Lai J., Porreca F. Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain. 79:1999;127-133.
29. Ozbarlas N., Sarikayalar F., Kale G. Congenital insensitivity to pain with anhidrosis. Cutis. 51:1993;373-374.
30. Pollock B.E., Phuong L.K., Foote R.L., Stafford S.L., Gorman D.A. High-dose trigeminal neuralgia radiosurgery associated with increased risk of trigeminal nerve dysfunction. Neurosurgery. 49:2001;58-62. (discussion p. 62-4).
31. Rosemberg S., Marie S.K., Kliemann S. Congenital insensitivity to pain with anhidrosis (hereditary sensory and autonomic neuropathy type IV). Pediatr Neurol. 11:1994;50-56.
32. Santos A.R., Calixto J.B. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. Neurosci Lett. 235:1997;73-76.
33. Smart D., Jerman J.C., Gunthorpe M.J., Brough S.J., Ranson J., Cairns W., Hayes P.D., Randall A.D., Davis J.B. Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur J Pharmacol. 417:2001;51-58.
34. Szabo T., Olah Z., Iadarola M.J., Blumberg P.M. Epidural resiniferatoxin induced prolonged regional analgesia to pain. Brain Res. 840:1999;92-98.
35. Szallasi A., Blumberg P.M. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience. 30:1989;515-520.
36. Szallasi A., Blumberg P.M. Vanilloid receptor loss in rat sensory ganglia associated with long term desensitization to resiniferatoxin. Neurosci Lett. 140:1992;51-54.
37. Szallasi A., Nilsson S., Farkas-Szallasi T., Blumberg P.M., Hokfelt T., Lundberg J.M. Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res. 703:1995;175-183.
38. Xu X.J., Farkas-Szallasi T., Lundberg J.M., Hokfelt T., Wiesenfeld-Hallin Z., Szallasi A. Effects of the capsaicin analogue resiniferatoxin on spinal nociceptive mechanisms in the rat: behavioral, electrophysiological and in situ hybridization studies. Brain Res. 752:1997;52-60.
39. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.